Offer - Urjas Oil for just ₹ 1
Imat 100 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Chronic Myelogenous Leukemia. The alternative uses of Imat 100 Tablet have also been explained below.
The optimal dosage of Imat 100 Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Imat 100 Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Imat 100 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Imat 100 Tablet is Severe for pregnant women and Moderate for women who are breastfeeding. Warnings related to Imat 100 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Some other conditions that can be affected by Imat 100 Tablet are listed in the contraindications section below.
Drug reaction of Imat 100 Tablet with other medicines has been reported. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Imat 100 Tablet is not safe while driving, and is is not addictive in nature.
Imat 100 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
2 - 12 years (Child) |
|
13 - 18 years (Adolescent) |
|
Is the use of Imat 100 Tablet safe for pregnant women?
Imat should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Imat 100 Tablet safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Imat. Immediately discontinue Imat if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Imat 100 Tablet on the Kidneys?
Imat may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Imat 100 Tablet on the Liver?
Very few cases of side effects of Imat on the liver have been reported.
What is the effect of Imat 100 Tablet on the Heart?
Imat may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
If you are suffering from any of the following diseases, you should not take Imat 100 Tablet unless your doctor advises you to do so -
Is this Imat 100 Tablet habit forming or addictive?
Imat 100 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Imat 100 Tablet. So it is best to avoid driving.
Is it safe?
Yes, Imat 100 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Imat 100 Tablet for mental disorders.
Interaction between Food and Imat 100 Tablet
You can take Imat 100 Tablet with food.
Interaction between Alcohol and Imat 100 Tablet
Information about the interaction of Imat 100 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gleevec (imatinib mesylate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 674-676
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869